Head-to-head · Cost-Efficiency Index
Aquivia Health vs Nex Gen Health Rx
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Aquivia Health
Cost-first shoppers who want clinician-reviewed compounded GLP-1 with optional branded upgrade.
Visit Aquivia HealthNex Gen Health Rx
Shoppers who want a named pharmacy and an itemized checkout, and who will read the homepage figure as the annual prepay it is.
Visit Nex Gen Health RxThe verdict
Aquivia Health and Nex Gen Health Rx tie on the Cost-Efficiency Index at 62/100, so neither wins outright on the numbers. For most shoppers we'd start with Aquivia Health (ranked #207, a hair above #208) — Cost-first shoppers who want clinician-reviewed compounded GLP-1 with optional branded upgrade. But Nex Gen Health Rx is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Aquivia Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Aquivia Health | Nex Gen Health Rx |
|---|---|---|
| Cost-Efficiency Index | 62/100 | 62/100 |
| Semaglutide / mo | $149/mo | $190 per 30-day supply month-to-month (the homepage's $99 is the 360-day prepay rate) |
| Tirzepatide / mo | $179/mo | $239 per 30-day supply month-to-month (the homepage's $149 is the 360-day prepay rate) |
| Semaglutide / yr (modeled) | $1,788 | $2,280 |
| Tirzepatide / yr (modeled) | $2,148 | $2,868 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #207 | #208 |
Aquivia Health
62/100Where the value is
- Clinical care provided by Open Loop Healthcare Partners, PC — a reused, verified MSO network
- Named leadership: Steven Bishop MD (CMO), Phillip Gray PharmD (Chief Pharmacist), Tom Foster (President)
- Itemized public pricing: compounded semaglutide $149/mo, tirzepatide $179/mo, Ozempic $1,299, Zepbound $1,399
The tradeoffs
- No public list of states served — you must complete intake to learn if your state qualifies
- No named 503A compounding pharmacy partner, limiting licensure verification
Nex Gen Health Rx
62/100Where the value is
- Names its pharmacy, Manifest Pharmacy, with a street address, and states the 503A class on the product pages
- The checkout itemizes what the price already covers, showing doctor support and monitoring at $99 and overnight shipping at $40 both marked free
- Full 30-, 90-, 180- and 360-day ladders for both molecules are reachable by a control on the product page, and the total was confirmed at checkout
The tradeoffs
- The homepage prints "for as low as $99.00 a month" and "$149.00 a month" with no basis stated; the basis appears only on a separate landing page, and it is a twelve-month plan paid in full
- That landing page sells $99 as "every month", "fixed price" and "price never increases" while its own fine print makes it conditional on $1,188 paid upfront
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.